SAKAR HEALTHCARE LTD Q3 RESULTS
Wipro margins, revenues beat estimates in Q3
Margins grew 4.8 per cent to touch 19.8 per cent on increased utilisation of workforce.
Sensex takes 336-point hit as ITC Q3 bites
NSE Nifty saw a similar fate and ended 91 points lower at 10,832.
Sensex, Nifty bank on RIL Q3 show, close higher
RIL was the top index gainer, climbing 4.34 per cent, after its Q3 results beat estimates.
Fortis Healthcare seeks extension till Feb 28 to announce Q2, Q3 results
Shares of the company closed 6.07 per cent down at Rs 139.30 on Monday.
Nifty, Sensex edge up ahead of RIL Q3 numbers
The BSE Sensex settled higher by 53 points, or 0.15 per cent, at 36,374.
Wipro reports 12% QoQ drop in Q3 profit at Rs 1,930 crore
Revenue from operations of the IT firm increased 1.83 per cent year-on-year to Rs 13669 crore
FIIs sell big in Q3 on rising oil, US bonds, strong dollar
FIIs net sold shares to the tune of Rs 19,797 crore in October-December last year.
TCS posts 1.3% QoQ rise in Q3 PAT, in line with estimates
ET Now poll had predicted a net profit of Rs 6532.70 crore in Q3FY18.
Cadila Healthcare tumbles nearly 11% intraday post Q3 results
Consolidated total income from operation of the company slipped 1.87 per cent to Rs 236.38 crore for the quarter under review against Rs 240.89 crore in the same quarter last year.
WNS reports 46% YoY jump in Q3 PAT, raises full-year guidance
It added 7 new clients in the quarter, expanded 7 existing relationships and renewed 9 contracts, the company said in its press release.
Pharma firms likely to post soft Q3, but low base may play saviour
The USFDA granted the highest-ever approvals in a single quarter with 246 clearances.
What changed your markets while you were sleeping
Nifty futures on the Singapore Exchange were trading 23 points, or 0.21 per cent.
New India Assurance Q3 net profit at Rs 617 crore
“The results have improved substantially due to improvement in combined ratio,” said G Srinivasan chairman and managing director New India Assurance.
Information technology sector may see muted Q3
A result of the slowness in banking and retail means Indian IT companies will also face slower growth in North America, their largest market.
Dr Lal PathLabs: Sweet pill in Dec quarter, expansion key to future growth
The main concern should be the company’s excessive concentration on the North market.
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service